We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RTW market cap is 511.7M. The company's latest EPS is USD -0.0123 and P/E is -94.31.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 81k | 154k | 658k | 2.17M | 4.17M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | -1.3M | -4.95M | -7.8M | -5.29M | -4.76M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 215.8M | 420.9M | 439.36M | 401.54M | 446.23M |
| Total Liabilities | 1.41M | 8.29M | 52M | 53.62M | 17.21M |
| Total Equity | 214.39M | 412.61M | 387.36M | 347.92M | 429.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -66.16M | -57.14M | -44.87M | 10.35M | 33.54M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 109.95M | 37.57M | 39.09M | N/A | -2.09M |
| Market Cap | 511.7M |
| Price to Earnings Ratio | -94.31 |
| Price to Sales Ratio | 107.41 |
| Price to Cash Ratio | 165.71 |
| Price to Book Ratio | 1.04 |
| Dividend Yield | - |
| Shares Outstanding | 386.19M |
| Average Volume (1 week) | 289.52k |
| Average Volume (1 Month) | 336.07k |
| 52 Week Change | -1.12% |
| 52 Week High | 1.73 |
| 52 Week Low | 1.27 |
| Spread (Intraday) | 0.03 (2.24%) |
| Company Name | Rtw Biotech Opportunities Ltd |
| Address |
po box 98 guernsey GY1 4BZ |
| Website | https://www.rtwfunds.com/venture-fund |
| Industry | trust,ex ed,religious,charty (6733) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
